US$ 20.66
glp-1 brain inflammation Glucagon-like peptide-1 suppresses neuroinflammation and improves neural structure Glucagon-like peptide 1(GLP-1) receptor agonists
Description
Code availability All codes described in the manuscript are available upon reasonable request to the corresponding authors

This article examines the relationship between GLP-1 therapy and dyspnea, reviews clinical evidence, and provides guidance on managing respiratory symptoms during treatment

Evidence suggests that the size of weight loss matters
doi:10.1016/j.exger.2005.10.006 Adibi SA, Fogel MR, Agrawal RM

Ethics declarations Conflict of interest The authors state that they have no conflict of interest to disclose
